Latest news about JHS Svendgaard Laboratories
JHS Svendgaard Laboratories
8.58
+0.21(+2.51%)
Company Performance:
View Company Insights1D+2.51%
1M-5.82%
6M-20.41%
1Y-38.45%
5Y-59.57%
More news about JHS Svendgaard Laboratories
01Apr 26
JHS Svendgaard Laboratories Opens Special Window for Physical Share Transfer Re-lodgement
JHS Svendgaard Laboratories Limited has opened a special one-year window from February 05, 2026 to February 04, 2027 for shareholders to re-lodge physical share transfer requests. This facility, mandated by SEBI circular dated January 30, 2026, covers transfer deeds lodged prior to April 01, 2019, including previously rejected or unattended requests. Shareholders can contact the company's Share Transfer Agent, M/s Beetal Financial & Computer Services Pvt. Ltd., for assistance with the re-lodgement process.
10Feb 26
JHS Svendgaard Laboratories Reports No Deviation in Fund Utilization for Q3FY26
JHS Svendgaard Laboratories Limited filed its Q3FY26 fund utilization report showing no deviation in the use of Rs. 29.99 crores raised through preferential issue on June 4, 2024. The company has strategically reallocated funds with shareholder approval, reducing the Jammu & Kashmir manufacturing project allocation from Rs. 2249.99 lakhs to Rs. 599.99 lakhs, while creating a new Rs. 1650.00 lakhs allocation for group entity expansion.
01Feb 26
JHS Svendgaard Laboratories Completes Warrant Conversion, Allots 18.02 Lakh Equity Shares
JHS Svendgaard Laboratories Limited completed the conversion of 18,01,801 warrants into equity shares at Rs. 27.75 per share on February 01, 2026. Coeus Global Opportunities Fund received the entire allocation, paying Rs. 3,74,99,983.31 as the balance amount and acquiring a 2.06% stake in the company. The conversion increased the company's paid-up equity share capital to Rs. 87,40,57,670, comprising 8,74,05,767 equity shares of Rs. 10.00 face value each.
14Nov 25
JHS Svendgaard Laboratories Approves 31.30 Lakh Employee Stock Options Under New ESOP Scheme
JHS Svendgaard Laboratories Limited has approved the grant of 31,30,000 employee stock options (ESOPs) under its new Employee Stock Option Scheme-2025. The options have a face value and exercise price of Rs. 10 each, with a grant date of November 14, 2025. The vesting period starts one year from the grant date and extends up to five years, with a maximum exercise period of 5 years from each vesting date. The scheme complies with SEBI regulations and aims to align employee interests with company performance.
22Sept 25
JHS Svendgaard Laboratories Reappoints Nikhil Nanda as Managing Director, Approves Key Appointments
JHS Svendgaard Laboratories Limited held its 21st AGM on September 20, 2025, making several important decisions. Shareholders approved the reappointment of Nikhil Nanda as Managing Director for a five-year term starting July 2, 2025. The company appointed M/s V.K. Khosla & Co as Statutory Auditors and M/s Dahiya & Associates as Secretarial Auditors, both for five-year terms. Mr. Vinay Mittal was appointed as a Director. The JHS Svendgaard Laboratories Limited - Employee Stock Option Scheme 2025 was also approved. Key resolutions, including financial statement adoption, passed with over 99% votes in favor.
Industry Peers
Godrej Consumer Products
Dabur India
Colgate Palmolive
P&G Hygiene and Health Care
Gillette
Emami
Cupid
Mamaearth
Bajaj Consumer Care
Anondita Medicare
1,027.50
(+1.00%)
451.05
(+0.94%)
2,156.90
(-0.37%)
9,585.00
(-0.78%)
7,783.50
(+1.68%)
402.90
(-3.07%)
120.31
(+0.12%)
384.35
(+6.62%)
571.75
(+4.59%)
1,103.05
(+3.46%)
we are part of Raise Financial Services
built with love
for indians who love to invest & trade
Market Community
Follow us on
